The joint research initiative between Samsung and Stanford Medicine aims to evolve the Galaxy Watch's sleep apnea capabilities from detection to proactive management. Led by sleep specialists Dr. Robson Capasso and Dr. Clete Kushida from Stanford University School of Medicine, the study will evaluate and refine the existing technology.

Samsung's sleep apnea detection feature, which received FDA De Novo authorization last year, currently works through the Health Monitor app to identify signs of moderate to severe obstructive sleep apnea in adults 22 and older.

The partnership's long-term goal is to enable daily monitoring of sleep apnea conditions and provide users with actionable insights and management tools, moving beyond simple detection to intervention.

"This collaboration with Stanford Medicine will combine our deep technological expertise with Stanford's leading research capabilities to unlock new innovation in preventive care," said Dr. Hon Pak, senior vice president and head of the digital health team and mobile eXperience business at Samsung Electronics. "Together, we aim to move beyond screening to also provide more meaningful daily support that helps people better understand and manage their sleep health."

The collaboration represents part of a broader trend in wearable technology's expansion into more sophisticated health monitoring. Last year, Samsung launched its Galaxy Watch Ultra featuring BioActive Sensors that provide detailed health metrics including blood oxygen levels, sleep quality, stress levels and heart rate.

Samsung's focus on sleep apnea detection has been developing steadily. In 2023, Korea's Ministry of Food and Drug Safety approved the sleep apnea feature in Samsung's Health Monitor app, allowing users to detect obstructive sleep apnea symptoms in early stages.

Other companies are also working on sleep apnea detection technology. Notably, Withings offers an under-the-mattress sleep sensor specifically designed to screen for sleep apnea, highlighting the growing importance of this health condition in the wearable and smart home health monitoring market.

As this partnership progresses, it potentially signals a shift in how consumer technology companies approach chronic health conditions, with increasing emphasis on continuous monitoring and proactive management rather than simple detection.

Click here for the original news story.